Needham analyst Mike Cikos maintains Datadog (NASDAQ:DDOG) with a Buy and raises the price target from $90 to $105.
Soleno Therapeutics Announces Initiation Of Randomized Withdrawal Study Of DCCR For Treatment Of Prader-Willi Syndrome
Soleno Therapeutics, Inc. (Soleno or the Company) (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it has initiated a